Related Experiment Video

Updated: Aug 9, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

MOZ fusion proteins in acute myeloid leukaemia

Philip J F Troke1, Karin B Kindle, Hilary M Collins

  • 1School of Pharmacy, University of Nottingham, University Park, Nottingham NG7 2RD, UK.

Biochemical Society Symposium
|April 22, 2006
PubMed

Insights

MOZ fusion proteins, resulting from chromosomal translocations, are implicated in acute myeloid leukaemia (AML) by disrupting normal blood cell development. These fusions interfere with key cellular functions, contributing to the disease

Area of Science:

  • Molecular Biology
  • Oncology
  • Hematology

Background:

  • MOZ (monocytic leukaemia zinc finger protein) is a MYST family protein acetyltransferase.
  • Chromosomal translocations involving MOZ are linked to acute myeloid leukaemia (AML), indicating a role in hematopoiesis.
  • Fusion proteins formed by MOZ translocations can transform hematopoietic progenitors and induce myeloproliferative disease.

Purpose of the Study:

  • To review recent progress in understanding the role of MOZ fusion proteins in AML etiology.
  • To elucidate the molecular mechanisms by which MOZ fusion proteins contribute to AML.
  • To highlight the interference of MOZ fusion proteins with transcription factors and co-activators.

Main Methods:

  • Review of recent scientific literature on MOZ fusion proteins and AML.
  • Analysis of molecular mechanisms involving transcription factors and co-activators.
  • In vitro transformation assays of hematopoietic progenitors.
  • In vivo studies of myeloproliferative disease induction in mice.

Main Results:

  • MOZ fusion proteins interfere with transcription factors like nuclear receptors, p53, and Runx proteins.
  • Subversion of cellular CBP (CREB-binding protein) and p300 protein function is a key mechanism.
  • MOZ fusion proteins derived from translocations with CBP, p300, or TIF2 are oncogenic.

Conclusions:

  • MOZ fusion proteins play a significant role in the development of AML.
  • Understanding these molecular mechanisms provides insights into AML pathogenesis.
  • Targeting MOZ fusion protein activity may offer therapeutic strategies for AML.

More Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...